Discover the reality of companies and brands!

Find by name : 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
by country : United States, Great Britain, Canada, Australia [+]
by top manager : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
The world's largest companies
by thema, in 2008 [previous month +] :
Restructuring and labor conditions [+], Human rights and money laundering [+]
Pollution [+]
Financial delinquency [+], more frequent offshore locations, best paid top managers [+]
Influence:corruption/lobby [+]
Information: dubious practice [+]

Free and independant information on large corporations

Bio-Technology General Corp

Headquarters : 70 Wood Ave. South Iselin, NJ 08830 United States of America

web www.biogenerica.com tel. 732-632-8800 stock : BTGC analytics

Brands

name

click to compare prices

Bio-Technology General, BIO-TROPIN

OXANDRIN

» Shop local, ethical and at the best price on Ethishop

« Ethical » rating of Bio-Technology General Corp , group and subsidiaries

Influence 1

[click on the rating for the method or on the number for the data]

Shareholders
Business & market
Subsidiaries
Locations & production (1)

country

address & contact : production type

incentive source

Israel

Bio-Technology General (Israel) Ltd :

» More locations of Bio-Technology General Corp
» The World map of tax haven, secret accounts and shell companies

Executives (1)

Labor conditions (1)

Environmental impact

Human impact

year

name

photo position; compensation

source

2000Fass, Sim

Chief Executive Officer;

» More executive salaries for Bio-Technology General Corp
» Highest paid executives in 2007

year

employees

social impact : country

source

2000

325

» More restructuring at Bio-Technology General Corp
» Layoff plans and labour conditions in 2007

year

employees

social impact : country

source

1 informations, access to subscribers

» More restructuring at Bio-Technology General Corp
» Layoff plans and labour conditions in 2007

Financials (1)

Lobbying & corruption (1)

Subsidy

Advertising & marketing

year

sales

income

source

2000

0,07

0,02

billion US$

» More financial data for Bio-Technology General Corp
» Financial delinquency in 2007

year

financial misdemeanor

sales

income

assets

buyback

source

1 informations, access to subscribers

» More financial data for Bio-Technology General Corp
» Financial delinquency in 2007

year

purpose : intermediary/lobby : institution

source

2000

Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate